Ingalls & Snyder LLC Omeros Corp Call Options Transaction History

Ingalls & Snyder LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 29, 2024	SELL	$1.08 - $3.63 $21,600 - $72,600	-20,000 Reduced 66.67%	10,000 $33,000
Q3 2023 Nov 02, 2023	BUY	$2.81 - $5.69 $84,300 - $170,700	30,000 New	30,000 $88,000
Q1 2023 May 09, 2023	BUY	$2.48 - $5.22 $6,200 - $13,050	2,500 New	2,500 $12,000
Q4 2021 Feb 11, 2022	BUY	$5.67 - $8.54 $102,627 - $154,573	18,100 New	18,100 $116,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $627M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.